Ranbaxy To Pay $40M To Settle Texas Medicaid Fraud Case
Indian pharmaceutical company Ranbaxy Laboratories Inc. has agreed to pay $39.75 million to settle a lawsuit with the state of Texas alleging the company reported inflated drug prices to the state...To view the full article, register now.
Already a subscriber? Click here to view full article